Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders

4 Jul 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurological disorders and treatments
Share to Neurotransmitter Receptor Influence on Behavior
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31273436
DOI: 10.1007/s00259-019-04396-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disordersPMID 31273436Read ↗

Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson’s diseaseSemantic proximity Read ↗

Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's diseaseSemantic proximity Read ↗

Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function; Not a New Concept, but Neglected Reality Simmering in Striatal StewSemantic proximity Read ↗

Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s diseaseSemantic proximity Read ↗

Beyond nigrostriatal dopamine transporter loss: whole-brain DAT depletion patterns discriminate PD phenotypes.Semantic proximity Read ↗

Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson’s diseaseSemantic proximity Read ↗

Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism.Semantic proximity Read ↗

Thyroid Hormone Transporters MCT8 and OATP1C1 are Expressed in Projection Neurons and Interneurons of Basal Ganglia and Motor Thalamus in the Adult Human and Macaque BrainSemantic proximity Read ↗

Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s DiseaseSemantic proximity Read ↗

Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA TreatmentSemantic proximity Read ↗

Different loss of dopamine transporter according to subtype of multiple system atrophySemantic proximity Read ↗

Comparison of dopamine transporter decline in a patient with Parkinson's disease and normal aging effectSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.